Management of Hemorrhagic Shock Secondary to Urosepsis in an 80-Year-Old Patient
Immediate aggressive resuscitation with fluid replacement, broad-spectrum antibiotics, and urgent urinary tract decompression via percutaneous nephrostomy (PCN) is the recommended approach for this elderly patient with hemorrhagic shock due to urosepsis from bilateral urethral stents and indwelling Foley catheter. 1, 2
Initial Resuscitation (First Hour)
Hemodynamic Stabilization
- Establish two large-bore IV access lines
- Initiate crystalloid fluid resuscitation (20-30 mL/kg) with balanced solutions
- Monitor response to fluid resuscitation:
- Target MAP ≥65 mmHg
- Monitor urine output, lactate clearance, and mental status
- If persistent hypotension despite initial fluid bolus, initiate vasopressors (norepinephrine preferred)
Antimicrobial Therapy
- Administer broad-spectrum antibiotics within the first hour
- Recommended regimen:
- Piperacillin-tazobactam or carbapenem plus an aminoglycoside
- Consider local resistance patterns and previous cultures if available
- Blood cultures (at least 2 sets) before antibiotic administration if possible without delaying treatment 2, 3
Urinary Source Control (Within 6 Hours)
Imaging Assessment
- If hemodynamically stable enough for transport: Urgent CT urogram with contrast to assess:
- Degree of obstruction
- Presence of collections/abscesses
- Extent of infection 1
- If too unstable for CT: Bedside ultrasound to confirm hydronephrosis and guide PCN placement
Urinary Tract Decompression
Percutaneous nephrostomy (PCN) is the preferred approach for this critically ill 80-year-old patient with bilateral urethral stents and indwelling Foley catheter 1
- PCN has 100% technical success rate compared to 80% for retrograde stenting 1
- PCN allows for direct drainage of infected urine
- PCN avoids manipulation of infected stents which could worsen sepsis
Remove the indwelling Foley catheter if it's contributing to the infection and replace with a new catheter if urinary output monitoring is necessary 4, 5
Timing Considerations
- Perform urinary decompression urgently (within 6 hours of presentation)
- If angioembolization facilities aren't available within 60 minutes, consider surgical pre-peritoneal pelvic packing with external fixation as a temporary measure 1
Ongoing Management
Antibiotic Management
- Adjust antibiotics based on culture results and clinical response
- Duration: Minimum 7-14 days depending on clinical response
- Consider prophylactic antibiotics during future stent exchanges based on urine culture results 1
Monitoring and Support
- ICU admission for close monitoring
- Serial laboratory assessments (CBC, comprehensive metabolic panel, lactate, coagulation studies)
- Consider additional supportive measures:
- Stress ulcer prophylaxis
- DVT prophylaxis when hemodynamically stable
- Nutritional support
Stent Management
- Plan for removal or exchange of infected stents once patient is stabilized
- Consider routine replacement every 3 months to prevent recurrent infections 1
- Evaluate for definitive management of underlying urological condition
Special Considerations for Elderly Patients
- More aggressive fluid resuscitation monitoring due to risk of volume overload
- Lower threshold for vasopressor support
- Higher risk of acute kidney injury - adjust medication dosing accordingly
- Increased risk of complications from prolonged catheterization 5
Prevention of Recurrence
- Routine stent exchanges every 3 months (or more frequently in high-risk patients) 1
- Consider antimicrobial prophylaxis for future procedures based on culture history
- Avoid concomitant use of Foley catheters with urethral stents when possible 1
- Maintain clean exit sites with antiseptic use and regular dressing changes 1
Hemorrhagic shock from urosepsis represents a life-threatening emergency with mortality rates of 30-40% 3. The key to successful management is rapid diagnosis, early goal-directed resuscitation, prompt antimicrobial therapy, and urgent control of the urinary source of infection through PCN placement 1, 2, 3.